Milestone scientific appoints pain management industry veteran dr. didier demesmin to its board of directors

Roseland, n.j., sept. 12, 2023 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of dr. didier demesmin, md, mba, to the board of directors.
MLSS Ratings Summary
MLSS Quant Ranking